Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:HUM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHUMHumana$258.91-1.6%$266.05$213.31▼$406.46$31.25B0.621.75 million shs2.47 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHUMHumana-0.32%+6.91%-0.33%-13.34%-14.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHUMHumana3.9628 of 5 stars2.15.02.53.92.91.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHUMHumana 2.26Hold$284.9010.04% UpsideCurrent Analyst Ratings BreakdownLatest HUM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/15/2025HUMHumanaRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$270.00 ➝ $300.004/11/2025HUMHumanaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$270.00 ➝ $322.004/11/2025HUMHumanaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$290.00 ➝ $325.004/9/2025HUMHumanaGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$326.004/9/2025HUMHumanaMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$305.00 ➝ $316.002/18/2025HUMHumanaJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$257.00 ➝ $256.002/13/2025HUMHumanaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$255.00 ➝ $270.002/12/2025HUMHumanaRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$283.00 ➝ $283.002/12/2025HUMHumanaCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$290.00 ➝ $290.002/12/2025HUMHumanaMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$301.00 ➝ $285.00(Data available from 4/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHUMHumana$117.76B0.27$22.77 per share11.37$136.57 per share1.90Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHUMHumana$1.21B$9.9526.0219.722.051.02%11.70%3.99%4/30/2025 (Estimated)Latest HUM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025HUMHumana$9.95N/AN/AN/A$32.00 billionN/A2/11/2025Q4 2024HUMHumana-$2.26-$2.16+$0.10-$5.76$28.84 billionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHUMHumana$3.541.37%+8.13%35.58%N/ALatest HUM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/17/2025HUMHumanaquarterly$0.88501.24%6/27/20256/27/20257/25/20252/20/2025HUMHumanaquarterly$0.88501.33%3/28/20253/28/20254/25/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHUMHumana0.681.761.76Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHUMHumana92.38%Insider OwnershipCompanyInsider OwnershipHUMHumana0.37%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHUMHumana67,100120.69 million120.03 millionOptionableHUM HeadlinesRecent News About These CompaniesHumana Earnings Are Up Next. The Stock’s Struggles Continue.April 29 at 7:45 PM | msn.comHumana Earnings Are Up Next. The Stock's Struggles Continue.April 29 at 4:30 PM | barrons.com5HUM : Insights Ahead: Humana's Quarterly EarningsApril 29 at 2:45 PM | benzinga.comWhy Investors Need to Take Advantage of These 2 Medical Stocks NowApril 29 at 9:51 AM | zacks.comHumana Earnings: What To Look For From HUMApril 29 at 8:51 AM | msn.comBanco Bilbao Vizcaya Argentaria S.A. Lowers Holdings in Humana Inc. (NYSE:HUM)April 29 at 5:39 AM | marketbeat.comStifel Financial Corp Trims Holdings in Humana Inc. (NYSE:HUM)April 29 at 4:56 AM | marketbeat.comWhen Hospitals Ditch Medicare Advantage Plans, Thousands of Members Get To Leave, TooApril 28 at 9:52 PM | msn.comCan Humana Beat Q1 Earnings Estimates on Growing Premiums?April 28 at 1:25 PM | zacks.comStay Ahead of the Game With Humana (HUM) Q1 Earnings: Wall Street's Insights on Key MetricsApril 28 at 10:22 AM | zacks.comVeriStar Capital Management LP Has $6.40 Million Stake in Humana Inc. (NYSE:HUM)April 28 at 6:53 AM | marketbeat.comPinebridge Investments L.P. Buys 3,000 Shares of Humana Inc. (NYSE:HUM)April 28 at 5:18 AM | marketbeat.comHumana Inc. (NYSE:HUM) Shares Bought by First Trust Advisors LPApril 28 at 4:27 AM | marketbeat.comHumana (HUM) Projected to Post Earnings on WednesdayApril 28 at 1:21 AM | americanbankingnews.comMilitary families demand answers as healthcare shift to TriWest causes issuesApril 28 at 12:36 AM | news4sanantonio.comTwo Sigma Securities LLC Sells 11,642 Shares of Humana Inc. (NYSE:HUM)April 27 at 6:58 AM | marketbeat.comPrice T Rowe Associates Inc. MD Decreases Holdings in Humana Inc. (NYSE:HUM)April 27 at 5:29 AM | marketbeat.comT. Rowe Price Investment Management Inc. Raises Stock Holdings in Humana Inc. (NYSE:HUM)April 26 at 6:02 AM | marketbeat.comState of Tennessee Department of Treasury Has $11.36 Million Stock Position in Humana Inc. (NYSE:HUM)April 26 at 5:34 AM | marketbeat.com2,171 Shares in Humana Inc. (NYSE:HUM) Bought by Symmetry Investments LPApril 25, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Buys New Stake in Humana Inc. (NYSE:HUM)April 25, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesAre Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?Signs of a more buyer-friendly housing market emerge for the spring homebuying seasonBy The Associated Press | April 6, 2025View Signs of a more buyer-friendly housing market emerge for the spring homebuying seasonIf You Wanted To Buy AbbVie and Didn’t, There’s Still Time To BuyBy Thomas Hughes | April 25, 2025View If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy2 Healthcare Recession-Resistant Stocks Unaffected by TariffsBy Jea Yu | April 15, 2025View 2 Healthcare Recession-Resistant Stocks Unaffected by TariffsHUM Company DescriptionsHumana NYSE:HUM$258.91 -4.29 (-1.63%) Closing price 03:59 PM EasternExtended Trading$258.80 -0.11 (-0.04%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Coca-Cola Company Stock Can Bubble to New Highs This Year Intel: Good Quarter, Bad Vibes, Guidance Rattles Investors Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet Domino’s Pizza Builds Leverage: Analysts Raise Price Targets 5 Mid-Cap Stocks Insiders Are Buying This Year Alphabet Rebounds After Strong Earnings and Buyback Announcement Occidental’s Hidden Gem: How OxyChem Could Boost Profits T-Mobile US: The Un-Carrier Is an Indisputable Buy on the Dip Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
